Medisobiznews: Songdo Bio Complex: A highly mature, commercialization-oriented bio cluster
Among Korea's biomedical clusters, the Songdo Bio Complex has been recognized as a highly mature production and commercialization-oriented complex. This type is similar to those like San Francisco, Ireland's NIBRT, and Singapore's Tuas — and while slightly less mature compared to those clusters, it scored highly in terms of commercialization and is considered to have strong potential for future development.
◇Songdo Bio Complex: The key focus areas are specialized in biosimilars, biopharmaceuticals, and CMO, with major companies as the core and favorable trade conditions due to proximity to the port and Incheon Airport.
Participating medical institutions include Gil Hospital and Inha University Hospital, with universities such as Ghent University, Yonsei University, University of Utah, Incheon Catholic University, University of Incheon, Inha University, Gachon University, SUNY Korea, and George Mason University Korea training approximately 4,500 personnel annually.
Participating research institutes include the Lee Gil-ya Cancer and Diabetes Institute, Gachon University College of Medicine Brain Science Institute, and private research institutes (Samsung Bioepis, SCM Life Science, Utah-Inha DDS Research Institute, Voronoi, and RudaCure), which conduct basic research.
Source: Medisobiznews (http://www.medisobizanews.com)
